日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer

化生性三阴性乳腺癌新辅助化疗-免疫疗法疗效的预测因素

Abuhadra, Nour; Pareja, Fresia; White, Charlie; Chen, Yuan; Wen, Hannah; Dikoglu, Esra; Park, Jinae; Downs-Canner, Stephanie; Norton, Larry; Plitas, George; Khan, Atif; Chandarlapaty, Sarat; Razavi, Pedram; Robson, Mark; Morrow, Monica; Montagna, Giacomo

IL-21 shapes the B cell response in a context-dependent manner

IL-21 以一种依赖于环境的方式影响 B 细胞反应。

Youngjun Kim ,Francesca Manara ,Simon Grassmann ,Kalina T Belcheva ,Kanelly Reyes ,Hyunu Kim ,Stephanie Downs-Canner ,William T Yewdell ,Joseph C Sun ,Jayanta Chaudhuri

Living in a Disadvantaged NYC Neighborhood Is Associated With Poorly Differentiated Breast Cancer and Shorter Breast Cancer-specific Survival

居住在纽约市贫困社区与乳腺癌分化不良和乳腺癌特异性生存期缩短有关。

Miller, Claire P; Le, Tiana; Amburn, Thomas; Sevilimedu, Varadan; Tadros, Audree B; Downs-Canner, Stephanie; Plitas, George; Barrio, Andrea; Morrow, Monica; Goel, Neha

Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer

早期三阴性乳腺癌新辅助化疗-免疫疗法病理完全缓解的预测因素

Perry, Lauren M; Sevilimedu, Varadan; Polidorio, Natalia; Abuhadra, Nour; Morrow, Monica; Plitas, George; Downs-Canner, Stephanie

Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer

改良的KEYNOTE522方案中,高剂量多柔比星联合环磷酰胺用于治疗三阴性乳腺癌

Mai, Nicholas; Myers, Sara; Shen, Sherry; Downs-Canner, Stephanie; Robson, Mark; Norton, Larry; Chen, Yuan; Traina, Tiffany; Abuhadra, Nour

At the Intersection of Intersectionality: Race and Gender Diversity Among Surgical Faculty and Trainees

交叉性视角下的交汇点:外科教职员工和学员中的种族和性别多样性

Iwai, Yoshiko; Yu, Alice Yunzi L; Thomas, Samantha M; Downs-Canner, Stephanie; Beasley, Georgia M; Sudan, Ranjan; Fayanju, Oluwadamilola M

Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer

新辅助化疗免疫疗法对三阴性乳腺癌手术结果和放疗时间的影响

Myers, Sara P; Sevilimedu, Varadan; Jones, V Morgan; Abuhadra, Nour; Montagna, Giacomo; Plitas, George; Morrow, Monica; Downs-Canner, Stephanie M

Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status

利用人工智能分析标本乳腺X线摄影图像以预测切缘状态

Chen, Kevin A; Kirchoff, Kathryn E; Butler, Logan R; Holloway, Alexa D; Kapadia, Muneera R; Kuzmiak, Cherie M; Downs-Canner, Stephanie M; Spanheimer, Phillip M; Gallagher, Kristalyn K; Gomez, Shawn M

Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

对于年龄≥50岁的早期激素受体阳性HER2阴性特殊组织学亚型乳腺癌女性患者,我们可以省略前哨淋巴结活检吗?

Knape, Nicole; Park, Ji-Hye; Agala, Chris B; Spanheimer, Philip; Morrow, Monica; Downs-Canner, Stephanie; Baldwin, Xavier L

A Review of Immune Checkpoint Blockade for the General Surgeon

面向普通外科医生的免疫检查点阻断疗法综述

Baldwin, Xavier L; Spanheimer, Philip M; Downs-Canner, Stephanie